Notably, although DDR1 mutations were detected in the NSCLC cohorts, no significant differences in survival or expression were detected between the mutant and wild-type groups (P > 0.05), and the difference in TMB between the DDR1 expression groups was not significant (P > 0.05). The gene discussed is DDR1; the disease is non-small cell lung carcinoma.